Jane Street’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $268M | Buy |
1,783,444
+1,778,641
| +37,032% | +$193M | 0.02% | 467 |
|
|
2026
Q1 | $444K | Sell |
4,803
-508,817
| -99% | -$51.1M | ﹤0.01% | 8344 |
|
|
2025
Q4 | $52.5M | Buy |
513,620
+436,641
| +567% | +$39.1M | 0.01% | 911 |
|
|
2025
Q3 | $4.81M | Buy |
+76,979
| New | +$4.19M | ﹤0.01% | 3477 |
|
|
2025
Q2 | – | Sell |
-31,873
| Closed | -$1.42M | – | 10083 |
|
|
2025
Q1 | $1.36M | Sell |
31,873
-133,962
| -81% | -$5.78M | ﹤0.01% | 5013 |
|
|
2024
Q4 | $5.07M | Buy |
165,835
+67,353
| +68% | +$1.89M | ﹤0.01% | 2640 |
|
|
2024
Q3 | $2.26M | Sell |
98,482
-105,494
| -52% | -$2.99M | ﹤0.01% | 4219 |
|
|
2024
Q2 | $5.89M | Sell |
203,976
-5,336
| -3% | -$124K | ﹤0.01% | 2722 |
|
|
2024
Q1 | $4.32M | Buy |
209,312
+27,398
| +15% | +$587K | ﹤0.01% | 2843 |
|
|
2023
Q4 | $4.92M | Buy |
181,914
+107,279
| +144% | +$2.81M | ﹤0.01% | 2878 |
|
|
2023
Q3 | $2.21M | Sell |
74,635
-49,099
| -40% | -$1.73M | ﹤0.01% | 3881 |
|
|
2023
Q2 | $4.43M | Sell |
123,734
-122,518
| -50% | -$3.52M | ﹤0.01% | 2924 |
|
|
2023
Q1 | $5.77M | Buy |
246,252
+53,742
| +28% | +$1.53M | ﹤0.01% | 2247 |
|
|
2022
Q4 | $5.24M | Buy |
192,510
+57,345
| +42% | +$2.62M | ﹤0.01% | 2413 |
|
|
2022
Q3 | $7.28M | Buy |
135,165
+59,832
| +79% | +$3.07M | ﹤0.01% | 2072 |
|
|
2022
Q2 | $3.04M | Sell |
75,333
-28,692
| -28% | -$1.42M | ﹤0.01% | 3421 |
|
|
2022
Q1 | $6.89M | Buy |
104,025
+87,260
| +520% | +$5.97M | ﹤0.01% | 2536 |
|
|
2021
Q4 | $1.68M | Buy |
16,765
+14,255
| +568% | +$1.47M | ﹤0.01% | 4831 |
|
|
2021
Q3 | $314K | Sell |
2,510
-74,994
| -97% | -$8.91M | ﹤0.01% | 8091 |
|
|
2021
Q2 | $9.63M | Buy |
77,504
+51,043
| +193% | +$6.87M | ﹤0.01% | 1762 |
|
|
2021
Q1 | $4.04M | Sell |
26,461
-73,509
| -74% | -$11.1M | ﹤0.01% | 2722 |
|
|
2020
Q4 | $12.9M | Buy |
99,970
+32,628
| +48% | +$3.75M | 0.01% | 1209 |
|
|
2020
Q3 | $7.53M | Sell |
67,342
-16,144
| -19% | -$1.48M | ﹤0.01% | 1451 |
|
|
2020
Q2 | $6.77M | Buy |
83,486
+64,610
| +342% | +$5.21M | 0.01% | 1514 |
|
|
2020
Q1 | $1.31M | Sell |
18,876
-7,291
| -28% | -$560K | ﹤0.01% | 2482 |
|
|
2019
Q4 | $2.04M | Buy |
26,167
+19,919
| +319% | +$1.44M | ﹤0.01% | 1916 |
|
|
2019
Q3 | $399K | Sell |
6,248
-6,163
| -50% | -$543K | ﹤0.01% | 3818 |
|
|
2019
Q2 | $1.07M | Buy |
+12,411
| New | +$948K | ﹤0.01% | 2611 |
|
Other funds holding GH
DTC
Jane Street's GH Position: Q2 2026 in Review
Jane Street increased its Guardant Health (GH) stake by 37,032% in Q2 2026, buying an estimated $193M and bringing the position to 1,783,444 shares worth $268M. The position accounts for 0.02% of the portfolio, ranked #467.
Jane Street first reported a position in GH in Q2 2019 and has held it in 28 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Jane Street held 1,783,444 shares of Guardant Health worth $268M as of Q2 2026.
- Jane Street bought 1,778,641 Guardant Health shares in Q2 2026, an estimated $193M.
- Guardant Health made up 0.02% of Jane Street's portfolio in Q2 2026, its #467 holding.
- Jane Street first reported a position in Guardant Health in Q2 2019 and has held it in 28 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.